Primecap Management CO Amgen Inc Transaction History

Primecap Management CO

$132 Billion
Q1 2024

A detailed history of Primecap Management CO transactions in Amgen Inc stock. As of the latest transaction made, Primecap Management CO holds 14,601,958 shares of AMGN stock, worth $4.47 Billion. This represents 3.15% of its overall portfolio holdings.

Number of Shares

14,601,958

Previous 14,591,468 0.07%

Holding current value

$4.47 Billion

Previous $4.2 Billion 1.21%

% of portfolio

3.15%

Previous 3.37%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $2.82 Million - $3.4 Million	10,490 Added 0.07%	14,601,958 $4.15 Billion
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $36.1 Million - $40.7 Million	-140,990 Reduced 0.96%	14,591,468 $4.2 Billion
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $869,571 - $1.08 Million	-3,977 Reduced 0.03%	14,732,458 $3.96 Billion
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $80.6 Million - $95.3 Million	-376,268 Reduced 2.49%	14,736,435 $3.27 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $40.5 Million - $49.4 Million	-179,510 Reduced 1.17%	15,112,703 $3.65 Billion

Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $62.4 Million - $79.3 Million	-272,657 Reduced 1.75%	15,292,213 $4.02 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $16.6 Million - $18.7 Million	-73,750 Reduced 0.47%	15,564,870 $3.51 Billion
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $20.2 Million - $22.4 Million	-87,435 Reduced 0.56%	15,638,620 $3.8 Billion
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $11 Million - $12.2 Million	-50,100 Reduced 0.32%	15,726,055 $3.8 Billion
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $61 Million - $69.8 Million	-306,532 Reduced 1.91%	15,776,155 $3.55 Billion
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $35.3 Million - $41.4 Million	-166,385 Reduced 1.02%	16,082,687 $3.42 Billion
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $99.4 Million - $110 Million	-425,500 Reduced 2.55%	16,249,072 $3.96 Billion
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $67.5 Million - $78.7 Million	-304,255 Reduced 1.79%	16,674,572 $4.15 Billion
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $92.7 Million - $110 Million	-428,255 Reduced 2.46%	16,978,827 $3.9 Billion
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $130 Million - $145 Million	-555,848 Reduced 3.09%	17,407,082 $4.42 Billion
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $102 Million - $126 Million	-517,160 Reduced 2.8%	17,962,930 $4.24 Billion
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $33.4 Million - $44.2 Million	183,075 Added 1.0%	18,480,090 $3.75 Billion
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $18.2 Million - $23.4 Million	96,414 Added 0.53%	18,297,015 $4.41 Billion
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $74.6 Million - $89.4 Million	-428,322 Reduced 2.3%	18,200,601 $3.52 Billion
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $67.3 Million - $78.9 Million	-403,945 Reduced 2.12%	18,628,923 $3.43 Billion
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $147 Million - $166 Million	-813,348 Reduced 4.1%	19,032,868 $3.62 Billion
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $169 Million - $197 Million	-947,226 Reduced 4.56%	19,846,216 $3.86 Billion
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $70.5 Million - $79.4 Million	-380,302 Reduced 1.8%	20,793,442 $4.31 Billion
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $44.6 Million - $50.1 Million	-268,600 Reduced 1.25%	21,173,744 $3.91 Billion
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $99.6 Million - $116 Million	-587,905 Reduced 2.67%	21,442,344 $3.66 Billion
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $38.7 Million - $43.2 Million	-229,109 Reduced 1.03%	22,030,249 $3.83 Billion
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.72 Billion - $4.25 Billion	22,259,358	22,259,358 $4.15 Billion

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Amgen Inc Transaction History